Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

218.66 -0.91 (-0.41%)
Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,021,536
Open 219.04
Bid (Size) 218.75 (100)
Ask (Size) 219.45 (100)
Prev. Close 219.57
Today's Range 218.13 - 220.11
52wk Range 141.50 - 220.11
Shares Outstanding 2,628,679,824
Dividend Yield 2.38%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Wall Street’s Comeback King: Citigroup Shatters M&A Records as Jane Fraser Sets a High Bar for 2026
Citigroup Inc. (NYSE: C) has emerged from its multi-year restructuring with a historic performance in its investment banking division, reporting record-breaking M&A advisory revenue for the 2025 fiscal... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Wall Street Renaissance: Goldman Sachs Posts Record $9.3 Billion in Fees as Dealmaking Roars Back
On January 15, 2026, Goldman Sachs (NYSE: GS) silenced critics of its strategic pivot by reporting a powerhouse fourth-quarter performance for 2025, headlined by a staggering $9.34 billion in annual... 
Via MarketMinute
Topics Credit Cards Earnings Economy

Performance

YTD
+5.5%
+5.5%
1 Month
+4.0%
+4.0%
3 Month
+13.2%
+13.2%
6 Month
+33.6%
+33.6%
1 Year
+48.0%
+48.0%

More News

Read More
News headline image
Citigroup Shakes Up Wall Street with Record M&A Revenue as Global Dealmaking Thaws
Via MarketMinute
Topics Economy
Johnson & Johnson (NYSE:JNJ) Stands Out as a Dependable Dividend Stock ↗
Via Chartmill
News headline image
"Animal Spirits" Return: Morgan Stanley Signals M&A Renaissance as Healthcare and Industrials Lead Shifting Landscape
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Johnson & Johnson Drug Slows Blood Cancer, Extends Survival In Pretreated Patients ↗
Via Benzinga
Topics Death
News headline image
Healthcare Titan Ascendant: Johnson & Johnson Hits All-Time Highs as It Navigates a New Political and Clinical Era
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Earnings
News headline image
FDA Reversal Sends Atara Biotherapeutics into Tailspin: Stock Plummets 67% on Second CRL for Tabelecleucel
Via MarketMinute
Topics Bankruptcy
News headline image
US Current Account Deficit Narrows to $226.4 Billion in Q3 2025: An Analysis of the Shift
Via MarketMinute
Topics Economy World Trade
News headline image
The 'Beautiful' Boom: How the 2025 Tax Overhaul is Fueling a 2026 Corporate Spending Spree
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
The Great Recalibration: Why 2026 Could Be Healthcare’s Year to Rebound
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Court Orders Recalculation Of Damages In Johnson & Johnson Auris Case ↗
Via Benzinga
News headline image
The Evolution of a Giant: A Deep Dive into the ‘New’ Johnson & Johnson (JNJ) in 2026
Via PredictStreet
Topics Artificial Intelligence Bankruptcy Economy
News headline image
2 No-Brainer Dividend Stocks to Buy Right Now ↗
Via The Motley Fool
Topics World Trade
News headline image
From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
This ETF Is Proof That the Healthcare Rebound Is Real ↗
Via MarketBeat
Topics ETFs
News headline image
2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio ↗
Via The Motley Fool
Topics Economy Intellectual Property Lawsuit
News headline image
The Grinch Who Stole Wall Street: Santa Claus Rally Fails for Third Straight Year, Echoing 1950s Slump
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The Trillion-Dollar Pharmacist: A 2026 Deep Dive into Eli Lilly (LLY)
Via PredictStreet
Topics Earnings Economy Intellectual Property
News headline image
Johnson & Johnson Secures Tariff Exemption Deal In Exchange For Drug Price Cuts ↗
Via Benzinga
Topics Government
J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs ↗
Via Stocktwits
Topics Government
News headline image
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
From Johnson & Johnson
Via Business Wire
News headline image
Johnson’s Junk Removal Launches Full-Service Junk Removal in Kenmore
Via Get News
News headline image
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
Via MarketMinute
Topics Intellectual Property
News headline image
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
From Johnson & Johnson
Via Business Wire

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 218.66
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 01/16/26 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 574.79B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 575B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.